Provided by Tiger Trade Technology Pte. Ltd.

Fractional Shares

2,018.41
-4.4603-0.22%
Number of Gainers:389
Number of Losers:616
Number of Flat:16
PE:- -
High:2,034.02
Open:2,022.92
Low:2,015.85
Close:2,022.87
Volume:4.99B
Turnover:649.19B
Market Cap:96.57T
Float Cap:90.40T

Loading ...

AGNC Investment (AGNC) Looks Undervalued On Paper, Is The Income Story Priced Fairly?

Simply Wall St.
·
Aug 27

Spheria Emerging Cos updates pre‑tax NTA after dividend

TIPRANKS
·
Aug 27

PayPal (PYPL) Stock Still Looks Like A Bargain After A 78% Slump

Simply Wall St.
·
Aug 27

PRL Global Declares AUD 0.03 Semi-Annual Dividend

TIPRANKS
·
Aug 27

How Investors May Respond To Pinterest (PINS) Partnering With Zillow To Embed Elevate Ads In Its Platform

Simply Wall St.
·
Aug 27

Nasdaq (NDAQ) Stock Could Be 13% Rich As Extended Trading Nears

Simply Wall St.
·
Aug 27

China Renaissance H1 Revenue Falls 3% as Management Fees Drop

Reuters
·
Aug 27

Altria Group (MO) Signs A New Manufacturing Pact, Is The Stock Still Undervalued?

Simply Wall St.
·
Aug 27

Jazz Pharmaceuticals (JAZZ) Stock May Be Undervalued As FDA Cancer Approval Lands

Simply Wall St.
·
Aug 27

China Pacific Insurance Unveils Interim Dividend Plan: 0.42 Yuan Per Share

Deep News
·
Aug 27

Malaysian Stocks Decline 0.4%

Dow Jones
·
Aug 27

SDS Group Malaysia 1st-Quarter 2026 Earnings Summary Table

Dow Jones
·
Aug 27

Goldman Sachs Adjusts Price Target on CrowdStrike to $230 From $208

MT Newswires Live
·
Aug 27

Semiconductor Stocks AMD, NVDA, Micron, and Broadcom Are Rising in Pre-Market Today. What’s Driving the Rally, August 27?

TIPRANKS
·
Aug 27

VEEM sets October AGM, invites shareholders to tour defence and marine facilities

TIPRANKS
·
Aug 27

PRL Global lodges updated ASX governance statement and Appendix 4G

TIPRANKS
·
Aug 27

Wing On Company Executes Share Buyback with HK$310,000 Transaction

Stock News
·
Aug 27

CrowdStrike price target raised to $240 from $230 at Jefferies

TIPRANKS
·
Aug 27

Yangtze Optical Fibre and Cable Joint Stock Co (YZOFF): New Buy Recommendation for This Technology Giant

TIPRANKS
·
Aug 27

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

TIPRANKS
·
Aug 27